All I wanted to say was that if the drug needs you to be positive on the test, and the ministry funds the drug only for the people who are positive, someone needs to figure out how we're going to get the test paid for, which labs we're going to contract with, how we'll know for sure that they have it. There is some action that happens in the implementation area. In addition to that about drugs changing, it may be that when you do the studies, you study one type of patient. It might get funded for that type of patient, and then things might be more attractive to other patients.
